Martin B. Silverstein M.D. — Executive Vice President of Strategy at Gilead Sciences

Dr. Martin B. Silverstein, also known as Marty, M.D., has been an Executive Vice President of Strategy at Gilead Sciences Inc. since May 24, 2016. Dr. Silverstein oversee Gilead's corporate development, commercial planning and alliance management functions. He served as Chief Strategy Officer at Anthem, Inc. since April 28, 2014 and its Executive Vice President until January 26, 2016. Dr. Silverstein joined WellPoint from The Boston Consulting Group (BCG) where he served as a Senior Partner and Managing Director. He spent 28 years in roles of increasing responsibility at The Boston Consulting Group. In his more than twenty-five years at BCG, Dr. Silverstein has held many leadership roles from establishing its U.S. Payers and Providers sector and having led its Global Health Care Practice. He has consulted to clients in most sectors of the health care industry, including managed care organizations, integrated delivery and hospital systems, biopharmaceutical manufacturers and retail pharmacies. Before joining BCG, he worked as a physician in private and corporate practice and as a senior scientist and project manager at the Health Data Institute. He completed his internal medicine residency at Boston's Beth Israel Hospital and is board certified in Internal Medicine. Dr. Silverstein holds a medical degree from the Yale University School of Medicine and is board certified in internal medicine. He received his MBA from Harvard Business School and earned his bachelor's degree in economics and natural sciences from the University of Pennsylvania.